Interpretation of the Consensus Document for Management of Retinoblastoma by India Council for Medical Research
10.3760/cma.j.cn115989-20250212-00035
- VernacularTitle:印度医学研究委员会视网膜母细胞瘤治疗与管理指南解读
- Author:
Yi SHAO
1
;
Liangqi HE
;
Qichen YANG
Author Information
1. 上海交通大学医学院附属第一人民医院眼科中心 国家眼病疾病临床医学研究中心，上海 200080
- Publication Type:Journal Article
- Keywords:
Retinoblastoma;
Intravenous chemotherapy;
Intra-arterial chemotherapy;
Radiotherapy
- From:
Chinese Journal of Experimental Ophthalmology
2025;43(9):839-845
- CountryChina
- Language:Chinese
-
Abstract:
Retinoblastoma (RB) is a malignant tumor that occurs mainly in children under 5 years of age.In recent years, the treatment of RB has been progressing, and the development of new methods and treatment strategies is of great significance to improve the survival rate and eye conservation rate of RB patients.However, in low- and middle-income countries, the number of patients with advanced RB is gradually increasing and the survival rate is declining due to poor economic conditions and limited medical resources.To this end, the Indian Council for Medical Research (ICMR) has drafted Consensus Document for Management of Retinoblastoma.This article interprets this document and provides personalized recommendations for the treatment and management of patients with intraocular and extraocular retinoblastoma in low- and middle-income countries based on the specific stage of unilateral/bilateral RB.
